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Background: Protein kinase B (PKB), and the p70 and p90 ribosomal S6
kinases (p70 S6 kinase and p90 Rsk, respectively), are activated by
phosphorylation of two residues, one in the ‘T-loop’ of the kinase domain and,
the other, in the hydrophobic motif carboxy terminal to the kinase domain. The
3-phosphoinositide-dependent protein kinase 1 (PDK1) activates many AGC
kinases in vitro by phosphorylating the T-loop residue, but whether PDK1 also
phosphorylates the hydrophobic motif and whether all other AGC kinases are
substrates for PDK1 is unknown. 
Results: Mouse embryonic stem (ES) cells in which both copies of the PDK1
gene were disrupted were viable. In PDK1–/– ES cells, PKB, p70 S6 kinase
and p90 Rsk were not activated by stimuli that induced strong activation in
PDK1+/+ cells. Other AGC kinases — namely, protein kinase A (PKA), the
mitogen- and stress-activated protein kinase 1 (MSK1) and the AMP-activated
protein kinase (AMPK) — had normal activity or were activated normally in
PDK1–/– cells. The insulin-like growth factor 1 (IGF1) induced PKB
phosphorylation at its hydrophobic motif, but not at its T-loop residue, in
PDK1–/– cells. IGF1 did not induce phosphorylation of p70 S6 kinase at its
hydrophobic motif in PDK1–/– cells.
Conclusions: PDK1 mediates activation of PKB, p70 S6 kinase and p90 Rsk
in vivo, but is not rate-limiting for activation of PKA, MSK1 and AMPK. Another
kinase phosphorylates PKB at its hydrophobic motif in PDK1–/– cells. PDK1
phosphorylates the hydrophobic motif of p70 S6 kinase either directly or by
activation of another kinase.
Background
Members of the AGC family of protein kinases, including
protein kinase B (PKB) [1–3], p70 ribosomal S6 kinase
(p70 S6 kinase) [4,5], p90 ribosomal S6 kinase (Rsk) [6],
protein kinase C (PKC) isoforms [7] and cyclic AMP
(cAMP)-dependent protein kinase (PKA) [8], mediate
many of the cellular effects of extracellular agonists by
phosphorylating key regulatory proteins. Recent work has
led to a greater understanding of how these protein
kinases are activated in cells. For example, PKB is turned
on following the agonist-induced activation of phospho-
inositide 3-kinase (PI 3-kinase). This generates the
second messenger phosphatidylinositol 3,4,5-trisphos-
phate (PtdIns(3,4,5)P3), leading to the recruitment of
PKB to the plasma membrane where it becomes activated
by phosphorylation of the Thr308 and Ser473 residues [9].
Thr308 lies in the ‘T-loop’ of the kinase domain, whereas
Ser473 is located carboxy terminal to the catalytic
domain, in a region termed the ‘hydrophobic motif’. PKC
isoforms [10], p70 S6 kinase [11], p90 Rsk [6,12] and the
serum- and glucocorticoid-regulated protein kinase
(SGK) [13,14] also possess residues, equivalent to Thr308
and Ser473 of PKB, whose phosphorylation is required for
activation and/or stabilisation of these kinases in vivo. 
The 3-phosphoinositide-dependent protein kinase 1
(PDK1) is thought to play a central role in activating AGC
kinases (reviewed in [1,15,16]). PDK1 phosphorylates the
T-loop residue of PKB [15–20], p70 S6 kinase [21,22], p90
Rsk [23,24], SGK [13,14], conventional and novel PKC iso-
forms [25,26], atypical PKC isoforms [26–28] and related
PKC isoforms [29,30] either in vitro, or when overex-
pressed in cells. PKA is also phosphorylated by PDK1
in vitro at the equivalent residue (Thr197) and this phos-
phorylation is required for PKA activity [31]. Other AGC
kinases, including the mitogen- and stress-activated
protein kinase-1 (MSK1) [32] and the AMP-activated
protein kinase (AMPK) [33], also possess a potential PDK1
motif at the equivalent T-loop residue, but whether these
kinases are substrates for PDK1 is not known.
PDK1 does not phosphorylate PKB significantly at Ser473,
either in vitro or in cotransfection experiments, which ini-
tially suggested that a distinct protein kinase catalysed this
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reaction [17,19]. More recently, however, the kinase
domain of PDK1 was found to bind the carboxy-terminal
77 residues of PKC-related kinase-2 (PRK2), termed the
PDK1-interacting fragment (PIF). In the presence of PIF,
PDK1 and PtdIns(3,4,5)P3 PKB was phosphorylated at
both Thr308 and Ser473 [34]. In contrast, PDK1 phospho-
rylates the hydrophobic motif of p70 S6 kinase in the
absence of the PIF, albeit to a very low stoichiometry, and
interaction with the PIF prevents PDK1 from phosphory-
lating p70 S6 kinase at this residue in vitro, as well as at the
T-loop threonine [35]. Moreover, in cells stimulated with
the insulin-like growth factor 1 (IGF1), overexpression of
the PIF, or a catalytically inactive mutant of PDK1, sup-
presses the phosphorylation of p70 S6 kinase at both
residues, suggesting that PDK1 activity is required for the
phosphorylation of the hydrophobic motif in vivo.
To gain further insights into the roles of PDK1 in cells, we
generated mouse embryonic stem (ES) cells in which both
copies of the PDK1 gene were disrupted. We found that,
although these cells were viable, PKB and p70 S6 kinase
were not activated by IGF1-stimulation, and p90 Rsk was
not switched on following stimulation with tetra-
decanoylphorbol 13-acetate (TPA). In contrast, PKA,
MSK1 and the AMPK were active, indicating that PDK1
is not rate limiting for the phosphorylation and activation
of these enzymes in ES cells. Our results also indicate that
ES cells contain a protein kinase, distinct from PDK1,
which phosphorylates PKB at its hydrophobic motif.
Results
Generation of mouse ES cells lacking PDK1
We generated ES cells in which both copies of the PDK1
gene were disrupted by removal of exons 3 and 4, which
encode the amino-terminal part of the kinase domain
(PDK1–/– cells; see the Materials and methods). The
resulting frame-shift mutation prevents expression of the
rest of the protein. We also generated ES cells in which
the PDK1 gene was not disrupted but exons 3 and 4 were
flanked by loxP sites (PDK1+/+ cells). PDK1–/– cells were
viable and proliferated at a similar rate to PDK1+/+ cells
(data not shown). A genomic Southern blot analysis
showed that both copies of the PDK1 gene had been dis-
rupted in the PDK1–/– cells (Figure 1a). Western blotting
of lysates derived from these cells using two different
PDK1 antibodies confirmed the absence of PDK1 protein
in the PDK1–/– cells (Figure 1b). Furthermore, no PDK1
activity was detectable following immunoprecipitation of
PDK1 from PDK1–/– cell lysates, whereas PDK1 activity
was readily detected in immunoprecipitates derived from
PDK1+/+ cells (Figure 1c). Following chromatography of
PDK1–/– and PDK1+/+ cell extracts on cation-exchange
(MonoQ) and anion-exchange (MonoS) columns, we
assayed for kinase activity capable of phosphorylating
PKB at Thr308 in the presence of lipid vesicles containing
PtdIns(3,4,5)P3 [17]. No activity was detected in lysates
derived from PDK1–/– cells, although PDK1-like activity
was readily detected in PDK1+/+ lysates (data not shown).
PKB is phosphorylated at Ser473 but not Thr308 in
PDK1–/– cells
PDK1+/+ and PDK1–/– ES cells were serum starved for
3 hours, then stimulated with IGF1, and PKBα immuno-
precipitated from the cell lysates and assayed. IGF1
induced a robust stimulation of PKBα activity in the
PDK1+/+ cells within 1–2 minutes, which was sustained for
up to 45 minutes. The addition of wortmannin for
10 minutes before stimulation with IGF1 reduced PKBα
activity to undetectable levels in control cells and pre-
vented its activation by IGF1 (Figure 2a). In contrast, no
PKBα activity was detected in PDK1–/– cells following
IGF1 stimulation (Figure 2a, right panel), despite PKBα
being expressed at a level similar to that in PDK1+/+ cells
(Figure 2b, lower panel). IGF1 also induced a fivefold
activation of PKBγ in PDK1+/+ cells, which attained a spe-
cific activity around fivefold lower than that of PKBα
(0.5 U/mg). No detectable PKBγ activity was present in
unstimulated or IGF1-stimulated PDK1–/– cells (data not
shown). No PKBβ protein was detected in lysates of ES
cells and, consistent with this observation, no PKBβ activ-
ity was observed either in the PDK1+/+ or PDK1–/– cells
following IGF1 stimulation (data not shown). 
Phosphorylation of PKB at Thr308 and Ser473 was mea-
sured by immunoblotting cell lysates with antibodies that
recognise PKB phosphorylated specifically at Thr308 or
Ser473. In unstimulated PDK1+/+ cells, PKB was phos-
phorylated to a very low level at Thr308 and Ser473. IGF1
induced a significant increase in the phosphorylation of
both residues, which was completely inhibited by preincu-
bation of the cells with wortmannin (Figure 2b, upper and
middle panels). In unstimulated PDK1–/– cells, Thr308 was
not phosphorylated and IGF1 failed to induce a detectable
phosphorylation of PKB at Thr308 (Figure 2b, upper
panel). In contrast, Ser473 was consistently phosphorylated
to a greater extent in the unstimulated PDK1–/– cells com-
pared with PDK1+/+ cells, and this increased 2–3-fold after
IGF1 stimulation. Preincubation of the cells with wortman-
nin virtually abolished Ser473 phosphorylation in either
unstimulated or IGF1-stimulated PDK1–/– cells (Figure 2b,
middle panel). To ensure that the antibodies were recog-
nising PKB and not a closely related protein, PKBα was
immunoprecipitated from cell lysates derived from control
and IGF1-stimulated cells, and the immunoprecipitates
again immunoblotted with the phosphorylation-specific
Thr308 and Ser473 antibodies. These experiments con-
firmed that IGF1 stimulation of PDK1–/– cells induced
phosphorylation of PKBα only at Ser473 and not Thr308
(data not shown). The Ser473 antibodies also recognised
PKBγ that was phosphorylated at its hydrophobic motif,
and IGF1 stimulation of PDK1–/– cells induced phosphory-
lation of immunoprecipitated PKBγ at its hydrophobic
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motif (data not shown). The phosphorylation-specific
Thr308 antibodies did not appear to recognise PKBγ phos-
phorylated at its T-loop residue (data not shown). 
Activation of PI 3-kinase in PDK1–/– cells
PI 3-kinase activity associated with either the insulin
receptor substrate-1 (IRS-1) (Figure 3a) or tyrosine-phos-
phorylated proteins (Figure 3b) was also measured in the
unstimulated and IGF1-treated PDK1–/– and PDK1+/+
cells. In unstimulated ES cells lacking PDK1, IRS1-asso-
ciated PI 3-kinase activity was reproducibly twofold
higher than that observed in PDK1+/+ cells, and stimula-
tion of both cells with IGF1 induced a 2–6-fold increase in
PI 3-kinase activity (Figure 3a,b). This may account for
the higher basal level of phosphorylation of PKB at Ser473
in the PDK1–/– cells (see discussion).
GSK3α is not phosphorylated at Ser21 in PDK1–/– cells
Glycogen synthase kinase-3 (GSK3) has multiple roles in
cell regulation and is one of the best characterised cellular
substrates of PKB (reviewed in [36]). PKB phosphorylates
GSK3α at Ser21, causing inactivation of this enzyme.
Phosphorylation of GSK3α at Ser21 in ES cells was
assessed by immunoblotting cell lysates with an antibody
that recognises the Ser21-phosphorylated form of GSK3α
In unstimulated PDK1+/+ cells, GSK3α was significantly
phosphorylated on Ser21, and phosphorylation at this
residue was increased twofold following stimulation with
IGF1 for 5 minutes. As expected, wortmannin signifi-
cantly inhibited phosphorylation of GSK3α in IGF1-stim-
ulated PDK1+/+ cells (Figure 3c, upper panel). GSK3α was
expressed at similar levels in PDK1–/– and PDK1+/+ cells
(Figure 3c, lower panel), but GSK3α phosphorylation at
Ser21 was undetectable in unstimulated or IGF1-stimu-
lated PDK1–/– cells (Figure 3a, upper panel).
The p70 S6 kinase is inactive and not phosphorylated at
Thr389 in PDK1–/– cells
The p70 S6 kinase is activated by insulin and growth factors
and mediates the phosphorylation of the 40S ribosomal
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Figure 1
Disruption of both copies of the PDK1 gene
prevents expression of PDK1. (a) Southern
blot probed with the recombination probe
(see Supplementary material) to detect clones
in which exons 3 and 4 of the PDK1 gene
were deleted. Following gene targeting, cells
that were homozygous for the floxed allele as
a result of a gene conversion event were
transfected with plasmid pMC–CrePuro (see
Supplementary material). Colonies were
expanded and DNA samples digested with
StuI and analysed by Southern blotting using
the recombination probe. The 5.3 kb band in
the +/+ tracks indicates that the neo cassette
has been deleted from both alleles in these
cell lines, and the 3.5 kb band in the –/–
tracks indicates that the neo cassette and
exons 3 and 4 have been deleted. This was
confirmed by stripping the blot and probing
with the neo probe (data not shown). (b) Two
independent clones of PDK1+/+ and PDK1–/–
cells were lysed, and 20 µg cell lysate protein
was electrophoresed on a 10%
SDS–polyacrylamide gel and immunoblotted
with antibodies raised against either the entire
PDK1 protein (antibody 1) or just the
carboxy-terminal portion (antibody 2). PDK1 in
the PDK1+/+ cells comigrates with a bovine
serum albumin (67 kDa) marker and is absent
in the PDK1–/– cells. (c) As in (b) except that
PDK1 was immunoprecipitated from 100 µg
cell lysate protein with either PDK1 antibody 1
or 2, and PDK1 was assayed with PDKtide as
substrate as described previously [47]. The
data are presented as the mean ± SEM for
two separate experiments, with each
determination carried out in triplicate.
Figure 2
PKB is not activated in PDK1–/– cells. (a) PDK1+/+ and PDK1–/– ES
cells were serum-starved for 3 h, then incubated for 10 min with or
without 100 nM wortmannin. The cells were either left unstimulated or
stimulated with 100 ng/ml IGF1 for the times indicated in the
continued presence or absence of wortmannin. The cells were lysed,
and PKBα was immunoprecipitated from the lysates and assayed. The
data are presented as the mean ± SEM of two separate experiments,
with each determination carried out in triplicate. (b) As in (a) except
that 20 µg cell lysate protein was electrophoresed on a 10%
SDS–polyacrylamide gel and immunoblotted with antibodies that
recognise the PKBα protein (PKBα total) or PKB phosphorylated
either at Thr308 (T308-P) or at Ser473 (S473-P).
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protein S6 [5], enabling the efficient translation of mRNA
molecules containing a polypyrimidine tract at their 5′ tran-
scriptional start site [37]. In unstimulated PDK1+/+ cells,
the p70 S6 kinase was significantly active and its activity
was increased twofold following stimulation with IGF1 for
45 minutes (the time at which p70 S6 kinase is maximally
activated, data not shown). As expected, rapamycin
reduced p70 S6 kinase activity to undetectable levels
(Figure 4). The p70 S6 kinase was expressed at similar
levels in the PDK1–/– and PDK1+/+ cells (Figure 4, lower
panel), but p70 S6 kinase activity was undetectable in
unstimulated or IGF1-stimulated PDK1–/– cells (Figure 4).
Phosphorylation of the p70 S6 kinase at Thr389 in the
hydrophobic motif was measured with a phosphorylation-
specific antibody. In unstimulated PDK1+/+ cells, p70 S6
kinase was significantly phosphorylated at Thr389, and this
was increased twofold by IGF1 stimulation, consistent
with the effect of IGF1 on activity. In contrast, rapamycin
induced the complete dephosphorylation of Thr389. No
phosphorylation of p70 S6 kinase at Thr389 was detected
in unstimulated or IGF1-stimulated PDK1–/– cells. We
have been unable to determine whether p70 S6 kinase is
phosphorylated at its T-loop residue in PDK1–/– cells as
the phosphorylation-specific antibodies that we have raised
against this epitope are not sensitive enough to detect the
phosphorylation of endogenous p70 S6 kinase at this
residue in a cell lysate (data not shown).
The p90 Rsk is not activated by TPA in PDK1–/– cells
The p90 Rsk is a well-established substrate for the
mitogen-activated protein kinase (MAP kinase) family
members ERK1 and ERK2 [6]. Stimulation of PDK1+/+
cells with TPA resulted in a sixfold activation of p90 Rsk
(Figure 5a), measured after its immunoprecipitation
from cell lysates with an antibody that recognises all p90
Rsk isoforms. As expected, activation of p90 Rsk was
largely prevented by preincubation of the cells with PD
98059, an inhibitor of the activation of MAP kinase
kinase-1 (data not shown). In contrast, p90 Rsk activity
was virtually undetectable in PDK1–/– cells and TPA
stimulation failed to induce activity, despite p90 Rsk
being expressed at similar levels in PDK1–/– and
PDK1+/+ cells (Figure 5a, lower panel). These results
were confirmed using p90 Rsk isoform-specific antibod-
ies. These experiments detected significant levels of
Rsk1, Rsk2 and Rsk3 activity in unstimulated PDK1+/+
cell lysates, each of which were activated approximately
threefold by TPA. No detectable Rsk1, Rsk2 or Rsk 3
activity was observed in either unstimulated or TPA-
stimulated PDK1–/– cells despite the expression of each
isoform at similar levels in PDK1–/– and PDK1+/+ cells
(data not shown).
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Figure 3
Phosphorylation of GSK3α at Ser21, and PI 3-kinase activity in PDK1–/–
cells. (a,b) ES cells were serum-starved for 3 h, then left unstimulated,
or stimulated with either 100 ng/ml IGF1 or 200 ng/ml TPA for 10 min.
The cells were lysed and PI 3-kinase was immunoprecipitated (IP)
from the same lysate with either (a) anti-IRS-1 antibodies or (b) anti-
phosphotyrosine antibodies and then assayed as described in the
Supplementary material. (c) The cells were stimulated, then lysed and
20 µg cell lysate protein electrophoresed on a 10% SDS–polyacrylamide
gel and immunoblotted with antibodies that recognise either GSK3α
phosphorylated at Ser21 (S21-P) or all GSK3α protein (GSK3α total).
Similar results were obtained in three separate experiments and the data
are presented as the mean ± SEM for three separate experiments, with
each determination carried out in triplicate (in the case of panels a,b).
Figure 4
The p70 S6 kinase is not activated or phosphorylated at its
hydrophobic motif in PDK1–/– cells. PDK1+/+ and PDK1–/– ES cells
were serum-starved for 3 h, then incubated for 10 min with or without
100 nM rapamycin. The cells were either left unstimulated or
stimulated with 100 ng/ml IGF1 for 45 min in the continued presence
or absence of rapamycin. The cells were lysed and p70 S6 kinase
was immunoprecipitated from the same lysate and assayed. The data
are presented as the mean ± SEM for three separate experiments,
with each determination carried out in triplicate. Cell lysate protein
(20 µg) was electrophoresed on a 10% SDS–polyacrylamide gel and
immunoblotted with antibodies that recognise either all p70 S6
kinase or just the Thr389-phosphorylated form (T389-P).
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TPA stimulation induced an upward shift in the elec-
trophoretic mobility of p90 Rsk in PDK1–/– cells to the
same extent as that observed in the PDK1+/+ cells
(Figure 5a, lower panel), suggesting that ERK1/ERK2 were
phosphorylating p90 Rsk in the PDK1–/– cells. This indi-
cates that p90 Rsk fails to become activated in the PDK1–/–
cells because it is not phosphorylated at the site targeted by
PDK1. To investigate this further, we incubated p90 Rsk
immunoprecipitates (derived from unstimulated and TPA-
stimulated cells), with PDK1 and Mg–ATP before assay.
We found that p90 Rsk, derived from either unstimulated
PDK1+/+ or PDK1–/– cells, or from TPA-stimulated PDK1+/+
cells, was not activated significantly by incubation with
Mg–ATP and PDK1 (Figure 5, compare panels a,b). Never-
theless, p90 Rsk derived from TPA-stimulated PDK1–/–
cells was partially re-activated following incubation with
PDK1 and Mg–ATP (Figure 5b). 
There is evidence that p90 Rsk phosphorylates GSK3α at
Ser21 when cells are stimulated with phorbol esters
(which do not induce PKB activation) and other growth
factors [38,39]. In the present study, stimulation of PDK1+/+
cells with TPA induced a significant increase in GSK3α
phosphorylation at Ser21 (Figure 3c) which, in contrast to
the IGF1-induced phosphorylation of GSK3α at Ser21,
was not prevented by prior incubation of the cells with the
PI 3-kinase inhibitor LY 294002 (data not shown). Consis-
tent with the lack of p90 Rsk activity in PDK1–/– cells, no
phosphorylation of GSK3α at this residue was detected in
TPA-stimulated PDK1–/– cells (Figure 3c).
ERK1/ERK2 were activated by TPA to a similar extent in
the PDK1–/– cells and PDK1+/+ cells, indicating that the lack
of p90 Rsk activation in the PDK1–/– cells is not due to defi-
cient MAP kinase activation. Interestingly, however, the
basal activity of ERK1/ERK2 was significantly higher in the
PDK1–/– cells compared with the PDK1+/+ cells (Figure 5c).
Furthermore, pre-incubation of cells with LY 294002
(100 µM) for 1 hour (Figure 5c) did not reduce (and even
slightly increased) ERK1/ERK2 activity in unstimulated or
TPA-stimulated PDK1–/– cells or PDK1+/+ cells, indicating
that the elevated PI 3-kinase activity in the PDK1–/– cells
(Figure 3) was not responsible for the increased basal
ERK1/2 in these cells (Figure 5c). Furthermore, LY 294002
had no significant effect on the TPA-induced activation of
p90 Rsk in the PDK1+/+ cells (data not shown).
MSK1 is activated in the PDK1–/– cells by TPA and
exposure to ultraviolet radiation
MSK1 is a protein kinase that is most similar to p90 Rsk
(40–50% identity), and is activated in vivo by two different
MAP kinase family members, namely ERK1/ERK2 and
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Figure 5
The kinase p90 Rsk is not activated in PDK1–/– cells. PDK1+/+ and
PDK1–/– ES cells were serum-starved for 3 h, then incubated in the
presence or absence of 100 µM LY 294002 (LY) for a further 1 h. The
cells were left unstimulated or stimulated with 200 ng/ml TPA for
15 min. (a) Following immunoprecipitation from the lysates, p90 Rsk
was assayed using Crosstide as a substrate; 20 µg cell lysate protein
was electrophoresed on a 10% SDS–polyacrylamide gel and
immunoblotted with an anti-p90 Rsk antibody. Incubation of cells with
LY 294002 had no effect on activation of p90 Rsk in PDK1+/+ cells
(data not shown). (b) To verify that PDK1 could activate p90 Rsk from
PDK1–/– cells, p90 Rsk immunoprecipitates derived from unstimulated
and TPA-stimulated PDK1+/+ and PDK1–/– ES cells were incubated
with 8 µg/ml PDK1 in the presence of Mg–ATP before assaying for p90
Rsk activity as described in the Supplementary material.
(c) ERK1/ERK2 were immunoprecipitated from the lysates with an
antibody that recognises both isoforms of this kinase and assayed
against myelin basic protein; 20 µg cell lysate protein was
electrophoresed on a 10% SDS–polyacrylamide gel and
immunoblotted with antibodies that recognise either ERK1 and ERK2
protein (ERK1/2) or activated phosphorylated ERK1 and ERK2
(Phospho-ERK1/2). The error bars represent ± SEM for a single
experiment. Similar results were obtained in three separate experiments.
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p38 MAP kinase [32]. The amino-acid sequences sur-
rounding the T-loop motif of p90 Rsk isoforms and
MSK1 are identical, suggesting that MSK1 should also be
a substrate for PDK1. Stimulation of the PDK1+/+ cells
with TPA or exposure to ultraviolet (UV) radiation,
induced a large activation of MSK1 (Figure 6a). As
expected, the activation of MSK1 by TPA was largely pre-
vented by preincubating the cells with PD 98059, while
the UV-induced activation was prevented by pretreatment
with SB 203580, an inhibitor of p38 MAP kinase (data not
shown). Surprisingly, however, MSK1 was activated by
TPA and by UV radiation to a similar extent in the
PDK1–/– and PDK1+/+ cells (Figure 6a). 
PKA is active in the PDK1–/– cells
PKA activity was measured in cell lysates derived from
the PDK1+/+ and PDK1–/– cells. In both cell lysates, the
specific activity of PKA was found to be similar, and
activity was stimulated by the addition of cAMP. In con-
trast, addition of the PKA inhibitor peptide, PKI, to the
assays, a specific peptide inhibitor of PKA, strongly sup-
pressed activity (Figure 7a). To confirm this result, we
measured PKA activity following its immunoprecipitation
from PDK1–/– and PDK1+/+ cell lysates using a specific
antibody. This assay confirmed that the specific activi-
ties of PKA were similar in the PDK1–/– and PDK1+/+
cells (data not shown). Western blotting of the ES cell
lysates indicated the presence of two closely migrating
PKA isoforms that were expressed at similar levels in
both the PDK1–/– and PDK1+/+ cells (Figure 7b). 
We generated antibodies that only recognise Thr197-
phosphorylated PKA, the site of PDK1 phosphorylation.
These antibodies recognised active PKA purified from
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Figure 6
MSK1 is activated in PDK1–/– cells and in PDK1+/+ cells. ES cells
were serum-starved for 4 h and then left unstimulated or stimulated
with TPA (200 ng/ml, 15 min) or exposed to UV radiation (200 J/m2,
followed by incubation at 37°C for 30 min). MSK1 was
immunoprecipitated and assayed using, as substrate, a fusion protein
between CREB (cyclic AMP response element binding protein) and
glutathione-S-transferase (see the Supplementary material). The error
bars represent ± SEM for a single experiment. Similar results were
obtained in three separate experiments.
Figure 7
PKA is activated in PDK1–/– cells. (a) PDK1+/+
and PDK1–/– ES cells were lysed and PKA
assayed in the cell lysates in the presence or
absence of 10 µM cAMP or 5 µM PKI (see the
Supplementary material). The error bars
represent the average ± SEM for three
separate experiments, with each determination
carried out in triplicate. (b) Cell lysate protein
(20 µg) was electrophoresed on a 10%
SDS–polyacrylamide gel and immunoblotted
with an antibody raised against a carboxy-
terminal peptide of the PKAα catalytic subunit;
the antibody is also known to crossreact with
PKAβ and PKAγ isoforms. (c) PKA was affinity
purified from 0.5 mg cell lysate derived from
PDK1–/– cells and PDK1+/+ cells (see the
Supplementary material) and immunoblotted
with either the anti-PKA antibody (PKA total)
used in (b) or an antibody that recognises
Thr197-phosphorylated PKA (P-Thr197
antibody). The P-Thr197 immunoblots were
also incubated with either the phosphorylated or
unphosphorylated Thr197 peptide immunogen
used to raise the antibody. PKA affinity purified
from distinct ES cell lysates in two separate
experiments was electrophoresed in parallel.
PKA purified from bovine heart (1 µg) was used
as a control. The PKA isoform that interacts
with PKI–Sepharose resin corresponds to the
lower molecular weight species observed in the
immunoblot shown in (b).
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bovine heart and their specificity for Thr197-phosphory-
lated PKA was established by the fact that recognition was
abolished by preincubating the antibody with the phos-
phopeptide immunogen used to raise the antibody,
whereas the dephosphorylated form of this peptide had no
effect (Figure 7c). As this antibody was not sufficiently
sensitive to detect phosphorylated PKA in ES cell extracts
(data not shown), we affinity purified PKA from a cell
lysate using PKI covalently coupled to Sepharose (see
Supplementary material) before immunoblotting with the
phosphorylation-specific Thr197 antibody. Using this pro-
cedure, we found that PKA extracted from either the
PDK1–/– cells or PDK1+/+ cells was similarly phosphory-
lated at Thr197 (Figure 7c).
AMPK is active in the PDK1–/– cells
AMPK is an AGC kinase that is activated by depletion of
ATP, which then inhibits ATP-consuming anabolic path-
ways [40]. AMPK was assayed in PDK1–/– and PDK1+/+
cells following immunoprecipitation from the cell lysates
with specific antibodies raised against the α1 isoform.
AMPK displayed similar activity in cell lysates derived
from unstimulated PDK1–/– or PDK1+/+ cells, being acti-
vated twofold by the addition of AMP (Figure 8). Expo-
sure of these cells to sodium arsenite, which depletes ATP
and activates AMPK [41] by triggering its phosphoryla-
tion, did not increase its activity further (data not shown).
Thus, AMPK appears to be highly active even in the
unstimulated ES cells. Western blotting of the ES cell
lysates indicated that the α1 isoform was expressed at
similar levels in both the PDK1–/– and PDK1+/+ cells
(Figure 7b). The α2 isoform of AMPK also displayed
similar activity in cell lysates derived from unstimulated
PDK1–/– or PDK1+/+ cells (data not shown).
Discussion
We found that mouse ES cells lacking PDK1 are viable
and proliferate at a similar rate to control ES cells express-
ing PDK1. This finding is somewhat surprising as disrup-
tion of the genes encoding PDK1 homologues in budding
yeast [42,43] or fission yeast [44] result in a lethal pheno-
type in all growth conditions tested, suggesting that acti-
vation of one or more AGC kinases is essential for cell
survival and/or proliferation in yeast. The viability of
PDK1–/– ES cells is useful as it enables us to test the role
of PDK1 in regulating AGC kinases in mammalian cells. 
IGF1 activated PI 3-kinase in cells lacking PDK1
(Figure 3), but did not induce activation of PKB or phos-
phorylation of PKB at Thr308 (Figure 2). Consistent
with this finding, GSK3α, a well-characterised intracel-
lular substrate for PKB, was not phosphorylated at the
site of PKB phosphorylation in unstimulated or IGF1-
stimulated PDK1–/– cells (Figure 3c). This establishes
that, in mammalian cells, PDK1 does indeed mediate
the phosphorylation of PKB at Thr308, leading to its
activation, and provides further evidence that GSK3 is
phosphorylated by PKB in cells. 
Significantly, PKB was phosphorylated at Ser473, even in
unstimulated PDK1–/– cells, and this was increased about
twofold following stimulation with IGF1. Preincubation of
cells with wortmannin reduced the level of Ser473 phos-
phorylation to below basal levels in both unstimulated and
IGF1-treated PDK1–/– cells (Figure 2). Thus, ES cells
lacking PDK1 contain a kinase distinct from PDK1,
termed PDK2, which is capable of phosphorylating PKB
at Ser473, and whose activity towards PKB is dependent
on PI 3-kinase. In our previous studies, we found that
PDK1 was capable of phosphorylating PKB at Ser473 as
well as Thr308 in the presence of the carboxy-terminal
fragment of PRK2 (PIF; see Background). We also found
that the major endogenous activity in brain cytosol that
phosphorylated Ser473 of PKB in a PtdIns (3,4,5)P3-
dependent manner was immunoprecipitated with a PDK1
antibody. In view of these findings, it is unclear whether
this activity comprises PDK1 complexed to a ‘PIF-like’
protein and/or PDK1 complexed to a distinct PDK2. A
recent study by Toker and Newton [45] suggests that fol-
lowing phosphorylation of PKB at Thr308, PKB autophos-
phorylates itself at Ser473. The finding in this paper that
Ser473 of PKB is phosphorylated in PDK1–/– ES cells in
the absence of Thr308 phosphorylation (Figure 2) argues
against this possibility.
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Figure 8
AMPK is activated in PDK1–/– cells. PDK1+/+ and PDK1–/– ES cells
were lysed and the α1 isoform of AMPK assayed after its
immunoprecipitation from the cell lysates in the presence or absence
of 100 µM AMP. The error bars represent the average ± SEM for two
separate experiments, with each determination carried out in triplicate.
Cell lysate protein (20 µg) was electrophoresed on a 10%
SDS–polyacrylamide gel and immunoblotted with an antibody that
recognises the α1 isoform of AMPK.
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The higher level of Ser473 kinase activity in cells lacking
PDK1 may result from the twofold higher level of PI
3-kinase activity observed in these cells compared with
PDK1+/+ cells (Figure 3). This result suggests that PDK1,
PKB, another PDK1-activated AGC kinase, or one of
their substrates, triggers a negative feedback pathway
that reduces PI 3-kinase activity and/or PDK2 activity in
unstimulated cells. Consistent with this model, Roth and
colleagues have shown that PKB phosphorylates IRS-1
in vitro and that this may inhibit its ability to activate PI
3-kinase [46].
In unstimulated PDK1+/+ cells, p70 S6 kinase was partially
active and phosphorylated at Thr389 in its hydrophobic
motif and its activity increased twofold in response to
IGF1. Strikingly, however, p70 S6 kinase was completely
inactive and not detectably phosphorylated at Thr389 in
PDK1–/– cells (Figure 4). These findings are consistent
with our previous observations that PIF inhibits the
PDK1-catalysed phosphorylation of Thr389 in vitro, and
prevents the phosphorylation of p70 S6 kinase at its
T-loop residue and hydrophobic motif in cotransfection
experiments [35]. These observations do not resolve the
issue of whether PDK1 (perhaps bound to a regulatory
protein) directly phosphorylates p70 S6 kinase at its
hydrophobic motif, or whether PDK1 activates (or regu-
lates the expression of) a distinct protein kinase that phos-
phorylates p70 S6 kinase at the hydrophobic motif.
We have recently identified a hydrophobic pocket on the
kinase domain of PDK1 with which PIF interacts [47].
Our experiments indicate that this PIF-binding pocket
enables PDK1 to interact with many of its substrates
including p70 S6 kinase and atypical PKC isoforms but
not PKB. PDK1 is unable to interact with or phosphory-
late p70 S6 kinase in the presence of PIF [35] and this is
also true for SGK (T. Kobayashi and P.C., unpublished
work) and for PKCζ and PRK2 (A.B., R. Biondi and
D.R.A., unpublished data). These observations suggest
that PDK1 substrates such as p70 S6 kinase, PKCζ and
PRK2 interact with PDK1 at a site that overlaps with the
PIF-binding site, before they are phosphorylated by
PDK1. In contrast, this is not the case for PKB as the
phosphorylation of PKB by PDK1 is not inhibited in the
presence of PIF either in vitro or in 293 cells transfected
with PIF and stimulated with IGF1 [35]. As PKB and
PDK1 both interact with 3-phosphoinositides through
their pleckstrin homology (PH) domains, it is possible that
this lipid second messenger, and not a specific docking
site, is an important determinant for colocalising these
molecules at the plasma membrane, hence allowing PDK1
to phosphorylate PKB [48]. 
The p90 Rsk isoforms are unusual in that they contain two
protein kinase domains within a single polypeptide. The
role of the carboxy-terminal kinase domain is to activate
the amino-terminal kinase domain, allowing the latter to
phosphorylate exogenous substrates [6,12]. The amino-
terminal domain possesses the highest homology to AGC
kinases, and a T-loop site (Ser222 in p90 Rsk1) and
hydrophobic motif (Ser381 in p90 Rsk1) that are similar to
those found in PKB and p70 S6 kinase. The phosphoryla-
tion of four residues (Ser222, Ser364, Ser381 and Thr574)
is essential for activation of p90 Rsk1. ERK1/ERK2 phos-
phorylate Thr574 in the carboxy-terminal domain and
Thr360 and Ser364 which are located between the amino-
terminal and carboxy-terminal kinase domains. The phos-
phorylation of Thr574 activates the carboxy-terminal
kinase domain, which then phosphorylates Ser381. PDK1
phosphorylates Ser222, activating p90 Rsk in vitro and in
cotransfection experiments [23,24]. Our finding that p90
Rsk is inactive in PDK1–/– cells, and partially activatable
by incubation with PDK1 and Mg–ATP (Figure 5), pro-
vides strong evidence that p90 Rsk is indeed a substrate
for PDK1 in vivo. 
Previous studies have shown that p90 Rsk1 is highly phos-
phorylated at the T-loop residue, even in unstimulated
cells, phosphorylation only increasing marginally in
response to TPA [12]. Consistent with this finding, p90
Rsk from unstimulated Swiss 3T3 cells can be fully acti-
vated by incubation with ERK1/ERK2 and Mg–ATP
in vitro [49]. Moreover, activation of p90 Rsk by TPA is
prevented by inhibitors of the ERK1/ERK2 cascade, but
not by inhibitors of PI 3-kinase in many cell types, includ-
ing PDK1+/+ ES cells (data not shown). These observa-
tions indicate that phosphorylation by PDK1 does not
activate p90 Rsk per se, but rather permits activation after
phosphorylation by ERK1/ERK2. Thus, unlike PKB and
p70 S6 kinase, the PDK1 site in p90 Rsk is phosphory-
lated constitutively in unstimulated cells.
Interestingly, ERK1/ERK2 activity was consistently about
twofold higher in unstimulated PDK1–/– cells than in
unstimulated PDK1+/+ cells (Figure 5c). This suggests that
PDK1 participates in a negative feedback pathway to sup-
press the activation of ERK1/ERK2 in these cells. This is
not mediated by the elevated PI 3-kinase activity observed
in PDK1–/– cells (Figure 3), because preincubation of the
cells with LY 294002 for 1 hour did not reduce the elevated
basal ERK1/ERK2 activity (Figure 5c). It has been pro-
posed that p90 Rsk phosphorylates and reduces the activity
of mSOS, the GDP–GTP exchanger for Ras [50]. There-
fore, mSOS may be more active in the PDK1–/– cells, which
lack p90 Rsk activity, resulting in higher levels of Ras–GTP
and a higher level of ERK1/ERK2 activity. Alternatively,
PKB activity in control PDK1+/+ cells may suppress the
basal level of ERK1/ERK2 activity by inhibiting Raf [51],
the protein kinase that lies downstream of Ras–GTP. If this
pathway operates in ES cells, the PDK1–/– cells that lack
PKB activity would be expected to have elevated Raf activ-
ity and, hence, a higher ERK1/ERK2 activity. 
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All PKC isoforms are activated by phosphorylation of their
T-loop residue, a reaction proposed to be mediated by
PDK1 [10]. It will therefore be important, in future work,
to establish whether PKC isoforms are active and phospho-
rylated in PDK1–/– cells. Nevertheless, as TPA still stimu-
lates the activation of the ERK pathway in PDK1–/– cells to
the same extent as in the PDK1+/+ cells (Figure 5c), one or
more PKC isoforms may be phosphorylated at their T-loop
residue in the PDK1–/– cells. It should also be noted that
there could be other kinases that are able to activate PKC
isoforms or other AGC kinases in cells, perhaps in response
to stimuli that we have not investigated. The activation of
other AGC kinases by a ‘PDK1-independent mechanism’
or the normal activation of the ERK1/ERK2 pathway,
could account for the viability of the PDK1–/– cells. 
The MSK isoforms (MSK1 and MSK2) are most closely
related to p90 Rsk and, like p90 Rsk, also contain two
protein kinase domains within a single polypeptide. All the
in vivo phosphorylation sites in p90 Rsk and the residues
surrounding them are conserved in MSK isoforms [32].
Moreover, the mutation of Thr212 to Ala, the residue
equivalent to the PDK1 site of p90 Rsk1, completely inac-
tivates MSK1 activity (J.S.C.A., unpublished observations).
Surprisingly, however, MSK1 was similarly activated in
PDK1–/– and PDK1+/+ cells (Figure 6). Thus, PDK1 activ-
ity is not rate limiting for the phosphorylation of MSK1 at
Thr212 in ES cells. Presumably, MSK1 is phosphorylated
at this site by another kinase, or by MSK1 itself. 
PDK1 phosphorylates PKA at its T-loop residue (Thr197)
in vitro and phosphorylation of this residue is required for
PKA activity [31]. Unlike other members of the AGC sub-
family, however, PKA is also able to phosphorylate itself at
this residue when expressed in bacteria, and thus it is
uncertain whether PKA itself or PDK1 mediates the phos-
phorylation of Thr197 in cells. The present study indi-
cates that PDK1 is not rate limiting for the
phosphorylation of PKA at Thr197 in ES cells, as PKA is
fully active in the PDK1–/– cells and phosphorylated at
Thr197 (Figure 7).
AMPK is activated in cells by the phosphorylation of a
threonine residue in its T-loop, [33,40], but the kinase
that mediates this phosphorylation has not yet been puri-
fied to homogeneity. We have been unable to activate
AMPK in vitro by incubating it with PDK1 in the presence
of Mg–ATP (D.R.A. and D.G. Hardie, unpublished obser-
vations). The finding that both mammalian AMPK iso-
forms are equally active in PDK1–/– cells and PDK1+/+
cells (Figure 8), provides further evidence that PDK1 does
not mediate the activation of AMPK in cells.
The constitutive PI 3-kinase-independent phosphorylation
of p90 Rsk at Ser222 in unstimulated cells indicates that this
residue is phosphorylated by a form of PDK1 that is active
in unstimulated cells. However, the form of PDK1 that acti-
vates PKB in vivo appears to be PtdIns(3,4,5)P3-dependent
for the following reasons. First, the activation of PKB by
PDK1 in vitro requires the binding of PtdIns(3,4,5)P3 to
PDK1 as well as PKB [48]. Second, insulin is still able to
induce the activation of a PKB mutant that lacks a PH
domain (and therefore cannot bind PtdIns(3,4,5)P3) and this
is prevented by inhibitors of PI 3-kinase [52]. When PDK1
is overexpressed in cells, a small but significant proportion
associates with the plasma membrane while the remainder
is cytosolic and excluded from the nucleus [48]. We there-
fore hypothesise that cells contain at least two forms of
PDK1; a plasma membrane-associated form that is PI(3,4,5)
P3-dependent and which activates PKB, and a cytosolic
form that is constitutively active and which phosphorylates
AGC family members such as p90 Rsk. As interaction with
PIF converts PDK1 from a PtdIns(3,4,5)P3-independent
form to a form that is activated by PtdIns(3,4,5)P3 [34], it is
possible that the membrane-associated form of PDK1 com-
prises PDK1 complexed to a ‘PIF-like’ molecule. The inter-
action of PIF with PDK1 also converts it to a form that is
capable of phosphorylating the hydrophobic motif as well as
the T-loop site. However, although the membrane-associ-
ated form of PDK1 may be capable of phosphorylating the
hydrophobic motif of PKB, the results presented here
demonstrate the existence of at least one further protein
kinase capable of phosphorylating this residue in vivo. The
identification and characterisation of this protein kinase(s)
remains a major challenge.
Supplementary material
A figure showing the mouse PDK1 gene structure and the knockout
strategy used, and additional methodological detail, are available at
http://current-biology.com/supmat/supmatin.htm.
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